<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://muscle.biouml.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Fedor</id>
		<title>Muscle - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="http://muscle.biouml.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Fedor"/>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php/Special:Contributions/Fedor"/>
		<updated>2026-05-16T05:46:00Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.29.2</generator>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=GBP1&amp;diff=33</id>
		<title>GBP1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=GBP1&amp;diff=33"/>
				<updated>2018-01-27T16:48:13Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Guanylate-binding protein 1  ====Action==== Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions: &amp;lt;br/&amp;gt;GTP + H2O = GDP + phosphate  Exhibits antiviral activity against in...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Guanylate-binding protein 1&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
Hydrolyzes GTP to GMP in 2 consecutive cleavage reactions:&lt;br /&gt;
&amp;lt;br/&amp;gt;GTP + H2O = GDP + phosphate&lt;br /&gt;
&lt;br /&gt;
Exhibits antiviral activity against influenza virus. &lt;br /&gt;
&lt;br /&gt;
Promote oxidative killing and deliver antimicrobial peptides to autophagolysosomes, providing broad host protection against different pathogen classes.&lt;br /&gt;
&lt;br /&gt;
GBP-1 is both necessary and sufficient for the inhibitory effects of IFN-γ on cell proliferation, migration, and invasion, as shown in endothelial cells and epithelial tumor cells&lt;br /&gt;
(17, 19, 34,–37 in &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;).&lt;br /&gt;
&lt;br /&gt;
Purified GBP-1 and actin bound to each other, and this interaction was sufficient to impair the formation of actin filaments in vitro &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Cosedimentation and band shift analyses demonstrated that GBP-1 binds robustly to globular actin and slightly to filamentous actin. &lt;br /&gt;
This indicated that GBP-1 may induce actin remodeling via globular actin sequestering and/or filament capping.&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;..&lt;br /&gt;
&lt;br /&gt;
GBP-1 colocalized with actin at the subcellular level and was both necessary and sufficient for the extensive remodeling &lt;br /&gt;
of the fibrous actin structure observed in IFN-γ-exposed cells. These effects were dependent on the oligomerization and the GTPase activity of GBP-1&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
An artificial backwards-moving myosin from three pre-existing molecular building blocks: &lt;br /&gt;
&amp;lt;br&amp;gt; - a forward-moving class I myosin motor domain, &lt;br /&gt;
&amp;lt;br&amp;gt; - a directional inverter formed by a four-helix bundle segment of human guanylate-binding protein-1 &lt;br /&gt;
&amp;lt;br&amp;gt; - an artificial lever arm formed by two alpha-actinin repeats. &lt;br /&gt;
&amp;lt;br&amp;gt;Reverse-direction movement of myosins can be achieved simply by rotating the direction of the lever arm 180 degrees &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
GBP-1 is a major IFN-γ-induced protein in eukaryotic cells (22, 66 in &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;).&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Chronic Active Epstein-Barr Virus Infection and Aneurysmal Bone Cysts.&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=24190970&lt;br /&gt;
#2 pmid=14765199&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises and after training.&lt;br /&gt;
&lt;br /&gt;
[[File:GBP1.png|GBP1 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:GBP1.png&amp;diff=32</id>
		<title>File:GBP1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:GBP1.png&amp;diff=32"/>
				<updated>2018-01-27T16:19:08Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=SERPINH1&amp;diff=31</id>
		<title>SERPINH1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=SERPINH1&amp;diff=31"/>
				<updated>2018-01-27T14:56:02Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Serpin H1 Synonim: 47 kDa heat shock protein  Member of the serpin superfamily of serine proteinase inhibitors. ====Action==== Binds specifically to collagen. Could be involve...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Serpin H1&lt;br /&gt;
Synonim: 47 kDa heat shock protein&lt;br /&gt;
&lt;br /&gt;
Member of the serpin superfamily of serine proteinase inhibitors.&lt;br /&gt;
====Action====&lt;br /&gt;
Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen.&lt;br /&gt;
&lt;br /&gt;
The change of HSP47, collagen specific molecular chaperone, expression in rat skeletal muscle may regulate collagen production with gravitational conditions&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
The gravity-regulated HSP47 may play a role in the maintenance of the extracellular matrix by modulating collagen production at the primary stage of adaptation&amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;..&lt;br /&gt;
&lt;br /&gt;
HSP47 may be involved in the repair or regeneration of muscle fibers in addition to the fibrotic change in the connective tissue&amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Pathways====&lt;br /&gt;
====Diseases====&lt;br /&gt;
Osteogenesis Imperfecta, Type X and Preterm Premature Rupture Of The Membranes&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=15858365&lt;br /&gt;
#2 pmid=17054723&lt;br /&gt;
#3 pmid=17324572&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises and after training.&lt;br /&gt;
&lt;br /&gt;
[[File:SERPINH1.png|SERPINH1 expression]]&lt;br /&gt;
&lt;br /&gt;
Hsp47 mRNA levels in cultured myoblasts increased significantly with hypergravity treatment at 40G for 2 h, and decreased with microgravity treatment at almost 0G for 1-2 h.&lt;br /&gt;
Collagen mRNA levels were also altered, although changes were slower and less pronounced compared with those for HSP47. &amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:SERPINH1.png&amp;diff=30</id>
		<title>File:SERPINH1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:SERPINH1.png&amp;diff=30"/>
				<updated>2018-01-27T14:20:32Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=NDRG1&amp;diff=29</id>
		<title>NDRG1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=NDRG1&amp;diff=29"/>
				<updated>2018-01-27T13:59:52Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;N-Myc Downstream Regulated 1.  It belongs to the alpha/beta hydrolase superfamily.  ====Action==== Acts as a tumor suppressor in many cell types. Necessary but not sufficient...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;N-Myc Downstream Regulated 1.&lt;br /&gt;
&lt;br /&gt;
It belongs to the alpha/beta hydrolase superfamily.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
Acts as a tumor suppressor in many cell types. Necessary but not sufficient for p53/TP53-mediated caspase activation and apoptosis. &lt;br /&gt;
&lt;br /&gt;
Has a role in cell trafficking, notably of the Schwann cell, and is necessary for the maintenance and development of the peripheral nerve myelin sheath. &lt;br /&gt;
&lt;br /&gt;
Required for vesicular recycling of CDH1 and TF. May also function in lipid trafficking. &lt;br /&gt;
&lt;br /&gt;
Protects cells from spindle disruption damage. Functions in p53/TP53-dependent mitotic spindle checkpoint. Regulates microtubule dynamics and maintains euploidy.&lt;br /&gt;
&lt;br /&gt;
This gene is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation. &lt;br /&gt;
&lt;br /&gt;
The mTORC2 substrate, phosphorylated protein kinase C α (PKCα), and the mTORC2 activity readout, phosphorylated N-myc downstream regulated 1 (NDRG1) protein increased with running in Ric WT mice,&lt;br /&gt;
but were not altered by running in Ric mKO muscle.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
The mammalian target of rapamycin complex 2 (mTORC2) is an important regulator of&lt;br /&gt;
muscle glucose uptake in response to insulin stimulation.&lt;br /&gt;
&lt;br /&gt;
p-NDRG1 T346 and p-mTOR S2481 have been characterized and used as in vivo markers of mTORC2 activity&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;&lt;br /&gt;
&lt;br /&gt;
SGK1 phosphorylates NDRG1 at three residues, T346, T356 and T366&lt;br /&gt;
It has been suggested that the phosphorylations of these residues are excellent surrogates of&lt;br /&gt;
mTORC2 activity. Thus, p-NDRG1 T346 has been widely used in this capacity of an mTORC2&lt;br /&gt;
biomarker&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Diseases====&lt;br /&gt;
Charcot-Marie-Tooth Disease, Type 4D and Congenital Hypomyelination Neuropathy&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=28464351&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:NDRG1.png|NDRG1 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:NDRG1.png&amp;diff=28</id>
		<title>File:NDRG1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:NDRG1.png&amp;diff=28"/>
				<updated>2018-01-27T13:49:23Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=ACTG1&amp;diff=27</id>
		<title>ACTG1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=ACTG1&amp;diff=27"/>
				<updated>2018-01-27T12:29:43Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Actin Gamma 1&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:ACTG1.png|ACTG1 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;br /&gt;
[[Category:actin]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=Category:Actin&amp;diff=26</id>
		<title>Category:Actin</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=Category:Actin&amp;diff=26"/>
				<updated>2018-01-27T12:23:55Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.  In vertebrates 3 main groups...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.&lt;br /&gt;
&lt;br /&gt;
In vertebrates 3 main groups of actin isoforms, alpha, beta and gamma have been identified. &lt;br /&gt;
&lt;br /&gt;
The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. &lt;br /&gt;
&lt;br /&gt;
The beta and gamma actins coexist in most cell types as components of the cytoskeleton and as mediators of internal cell motility.&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=ACTG1&amp;diff=25</id>
		<title>ACTG1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=ACTG1&amp;diff=25"/>
				<updated>2018-01-27T12:23:33Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Actin Gamma 1  See Actin  ====References==== &amp;lt;biblio&amp;gt; #1 pmid= &amp;lt;/biblio&amp;gt;  ====Expression==== Upregulated - after 1 hour after exercises.  File:ACTG1.png|ACTG1 expression...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Actin Gamma 1&lt;br /&gt;
&lt;br /&gt;
See [[Actin]]&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:ACTG1.png|ACTG1 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;br /&gt;
[[Category:actin]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:ACTG1.png&amp;diff=24</id>
		<title>File:ACTG1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:ACTG1.png&amp;diff=24"/>
				<updated>2018-01-27T12:18:45Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=TPM4&amp;diff=23</id>
		<title>TPM4</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=TPM4&amp;diff=23"/>
				<updated>2018-01-27T11:59:02Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Tropomyosin alpha-4 chain  Tropomyosins are dimers of coiled-coil proteins that polymerize end-to-end along the major groove in most actin filaments.   Multiple transcript var...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Tropomyosin alpha-4 chain&lt;br /&gt;
&lt;br /&gt;
Tropomyosins are dimers of coiled-coil proteins that polymerize end-to-end along the major groove in most actin filaments. &lt;br /&gt;
&lt;br /&gt;
Multiple transcript variants encoding different isoforms have been found for this gene.&lt;br /&gt;
====Action====&lt;br /&gt;
Binds to actin filaments in muscle and non-muscle cells. &lt;br /&gt;
&lt;br /&gt;
Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. &lt;br /&gt;
&lt;br /&gt;
Provides stability to the filaments and regulate access of other actin-binding proteins. In muscle cells, they regulate muscle contraction by controlling the binding of myosin heads to the actin filament. &lt;br /&gt;
&lt;br /&gt;
Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments (By similarity). &lt;br /&gt;
&lt;br /&gt;
Binds calcium (PubMed:1836432)&lt;br /&gt;
====Pathways====&lt;br /&gt;
====Diseases====&lt;br /&gt;
Inflammatory Myofibroblastic Tumor, Autosomal Dominant Macrothrombocytopenia. &lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:TPM4.png|TPM4 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:TPM4.png&amp;diff=22</id>
		<title>File:TPM4.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:TPM4.png&amp;diff=22"/>
				<updated>2018-01-27T11:46:27Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=CNN2&amp;diff=21</id>
		<title>CNN2</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=CNN2&amp;diff=21"/>
				<updated>2018-01-26T11:24:21Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Calponin 2.   Alternative splicing results in multiple transcript variants encoding different isoforms.  Calponin  ====Action==== Thin filament-associated protein that is...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Calponin 2. &lt;br /&gt;
&lt;br /&gt;
Alternative splicing results in multiple transcript variants encoding different isoforms.&lt;br /&gt;
&lt;br /&gt;
[[Calponin]]&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. &lt;br /&gt;
&lt;br /&gt;
The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity.&lt;br /&gt;
&lt;br /&gt;
It is capable of binding to actin, calmodulin, troponin C and tropomyosin. &lt;br /&gt;
&lt;br /&gt;
May function in the structural organization of actin filaments.  &lt;br /&gt;
&lt;br /&gt;
It could play a role in smooth muscle contraction and cell adhesion.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
Cytoskeleton tension regulates the transcription of CNN2 gene and the degradation of calponin 2 protein &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Regulated by transcriptional factor HES-1 (hairy and enhancer of split 1) in the 5′-upstream region of mouse Cnn2 promoter (Jiang et al., 2014)&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Deletion or mutation of the HES-1 site in mouse Cnn2 promoter abolished the mechanical regulation and resulted in a substrate stiffness independent high level of transcriptional activity. &lt;br /&gt;
Therefore, the regulatory mechanism is via a low tension-induced repression of transcription. &lt;br /&gt;
&lt;br /&gt;
Corresponding to the down-regulation of Cnn2 gene expression, the level of HES-1 increased in cells cultured on soft gel substrates in comparison with that in cells cultured on hard gels (Jiang et al., 2014). &lt;br /&gt;
HES-1 is known to function downstream of the Notch-RBP J signaling pathway (Kageyama et al., 1997), which has been suggested to mediate cellular mechanoregulations (Morrow et al., 2005; Morrow et al., 2007).&lt;br /&gt;
&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=26970176&lt;br /&gt;
#2 pmid=2500984&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:CNN2.png|CNN2 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;br /&gt;
[[Category:Calponin]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:CNN2.png&amp;diff=20</id>
		<title>File:CNN2.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:CNN2.png&amp;diff=20"/>
				<updated>2018-01-26T11:14:11Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=LRRC10&amp;diff=19</id>
		<title>LRRC10</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=LRRC10&amp;diff=19"/>
				<updated>2018-01-26T08:58:15Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Leucine-rich repeat containing protein (LRRC)10 is a cardiac-specific member of the LRRC superfamily.  ====Action==== LRRC10 has no other known functional domains other than i...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Leucine-rich repeat containing protein (LRRC)10 is a cardiac-specific member of the LRRC superfamily.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
LRRC10 has no other known functional domains other than its LRRs (28 in &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;), suggesting that it mediates its biological functions by interacting with other proteins.&lt;br /&gt;
&lt;br /&gt;
LRRC10 interacts with actin and α-actinin in the heart (8) and localizes at the dyad region where the Z-disc comes into close juxtaposition to the T-tubule and sarcoplasmic reticulum (8, 28).&lt;br /&gt;
&lt;br /&gt;
This places LRRC10 at a mechanosensitive signaling hub in cardiomyocytes (19).&lt;br /&gt;
&lt;br /&gt;
Lrrc10−/− mice exhibit increased cardiac growth in response to pressure overload &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Lrrc10−/− myocytes have reduced single cell contractility in response to adrenergic stimulation, &lt;br /&gt;
indicating that LRRC10 is indispensable for the response of the mammalian heart to biomechanical stress &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Deletion of Lrrc10 greatly exacerbates cardiac dysfunction in response to pressure overload &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
His150 of LRRC10 mediates its interaction with actin in the heart and that the interaction of LRRC10 with actin is reduced after pressure overload,&lt;br /&gt;
suggesting a potential mechanosensing function for LRRC10 &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
LRRC10 may serve as a cardiomyocyte-specific scaffolding protein to tether important structural or signaling molecules to mediate appropriate responses to mechanical stress. &lt;br /&gt;
Z-disc proteins such as muscle LIM protein (2, 29), Cypher (56, 57), and telethonin (29, 30) are thought to compose a mechanosensory signalosome &lt;br /&gt;
that allows the cardiomyocyte to internally sense and respond to mechanical stretch or strain &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Moreover, LRRC39, a striated muscle-specific LRRC, acts as a mechanosensor at the cardiomyocyte M-line by regulating serum response factor-dependent transcription (51).&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
The cardiomyocyte-specific expression of Lrrc10 is regulated by Nkx2.5, GATA4, and serum response factor (7).&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Mutations in the LRRC10 gene have been recently linked to human dilated cardiomyopathy (43).&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Lrrc10 is expressed exclusively in cardiomyocytes &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=26608339&lt;br /&gt;
#2 pmid=&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:mechanosensor]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=LRRC10B&amp;diff=18</id>
		<title>LRRC10B</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=LRRC10B&amp;diff=18"/>
				<updated>2018-01-26T08:38:03Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;LRRC10B (Leucine Rich Repeat Containing 10B) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
An important paralog of this gene is [[LRRC10]] - a cardiac-specific member of the LRRC superfamily.&lt;br /&gt;
May be function of LRRC10B is the same as [[LRRC10]].&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:LRRC10B.png|LRRC10B expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=LRRC10B&amp;diff=17</id>
		<title>LRRC10B</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=LRRC10B&amp;diff=17"/>
				<updated>2018-01-26T08:34:41Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;LRRC10B (Leucine Rich Repeat Containing 10B) is a Protein Coding gene.   An important paralog of this gene is LRRC10. ====Expression==== Upregulated - after 1 hour after e...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;LRRC10B (Leucine Rich Repeat Containing 10B) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
An important paralog of this gene is [[LRRC10]].&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:LRRC10B.png|LRRC10B expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:LRRC10B.png&amp;diff=16</id>
		<title>File:LRRC10B.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:LRRC10B.png&amp;diff=16"/>
				<updated>2018-01-26T08:28:04Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=Category:Muscle_DEGs&amp;diff=15</id>
		<title>Category:Muscle DEGs</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=Category:Muscle_DEGs&amp;diff=15"/>
				<updated>2018-01-26T07:36:28Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;List of differentially expressed genes in muscles after physical exercises.&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;List of differentially expressed genes in muscles after physical exercises.&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=14</id>
		<title>MEOX1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=14"/>
				<updated>2018-01-26T07:35:01Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development. &lt;br /&gt;
&lt;br /&gt;
Required for maintenance of the sclerotome polarity and formation of the cranio-cervical joints (PubMed:23290072, PubMed:24073994). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt; - The formation of skeletal muscle: from somite to limb&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
http://www.uniprot.org/uniprot/P50221#function&lt;br /&gt;
&lt;br /&gt;
Binds specifically to the promoter of target genes and regulates their expression. &lt;br /&gt;
&lt;br /&gt;
Activates expression of NKX3-2 in the sclerotome. &lt;br /&gt;
&lt;br /&gt;
Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation. &lt;br /&gt;
&lt;br /&gt;
While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner. &lt;br /&gt;
&lt;br /&gt;
Required for hematopoietic stem cell (HSCs) induction via its role in somitogenesis: &lt;br /&gt;
specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the somite named endotome.&lt;br /&gt;
&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 promotes vascular smooth muscle cells (SMCs) phenotypic modulation and injury-induced vascular remodeling by regulating the FAK-ERK1/2-autophagy signaling cascade&amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 initiates G2 cell-cycle arrest within muscle stem cells&amp;lt;cite&amp;gt;4&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Pax3 is both necessary and sufficient to induce skeletal myogenesis, Meox1 is required for Pax3 expression and subsequent myogenic differentiation ([21–23] in &amp;lt;cite&amp;gt;5&amp;lt;/cite&amp;gt;).&lt;br /&gt;
&lt;br /&gt;
Transduction of hAFS (human amniotic fluid stem) cells with MYOD lentiviruses induces skeletal myogenic differentiation in vitro and morphological and functional regeneration of injured muscle in vivo.&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;6&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
ERK1/2 for vascular smooth muscle cells (SMCs) &amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with MEOX1 include Klippel-Feil Syndrome 2 and Isolated Klippel-Feil Syndrome. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=12587921&lt;br /&gt;
#2 pmid=24331373&lt;br /&gt;
#3 pmid=29113690&lt;br /&gt;
#4 pmid=28686860&lt;br /&gt;
#5 pmid=28469839&lt;br /&gt;
#6 pmid=24331373 &lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise and has increased level after long training.&lt;br /&gt;
&lt;br /&gt;
[[File:MEOX1.png|MEOX1 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
VASP (0.89), CDC42EP1 (0.88), IQCJ-SCHIP1 (0.87), TES(0.87), ABRACL(0.87), KCNK6(0.87), TINAGL1(0.87), GLIS2(0.86), PCGF2(0.86), IL27RA(0.86), VWA1(0.86), PLEKHG2(0.85), PDGFB(0.85), &lt;br /&gt;
ENG(0.85), ERF(0.85), SHROOM1(0.84), FAM57A(0.84), ELFN1(0.84), PPP1R13L(0.84), ITGA5(0.84), RAB32(0.84), MYADM(0.84), RNF152(0.83), CNN2(0.83), CDR2L(0.83), TMC6(0.83),&lt;br /&gt;
ZBTB46(0.83), NOVA2(0.87), TGFB1I1(0.83), ELF4(0.83), PGM2(0.83), GBP1(0.83), PRKD2(0.83), NOL4L(0.82), SH2D3C(0.82), ZYX(0.82), TPM4(0.82), EPHA2(0.82), NECTIN2(0.82),&lt;br /&gt;
SERPINH1(0.82), ACTN4(0.82), MMRN2(0.81), TAL1(0.82), SPATA2L(0.81), TRIM47(0.81), TGFB1(0.81), MYH9(0.81), LCP2(0.81), YWHAH(0.81), BCL6B(0.81), DLL1(0.80),&lt;br /&gt;
TAGLN2(0.80), TBC1D9(0.80), SOX18(0.80), ID2(0.80), TAGLN2P1(0.80), MARCKSL1(0.80), MYL6P5(0.80), DLC1(0.79), ACTG1(0.79), HEYL(0.79), KCTD15(0.79), ...&lt;br /&gt;
&lt;br /&gt;
HOXA10(-0.76), CLCN1(-0.71), KIF1C(-0.70), ZNF865(-0.68), RYR1(-0.67), ZC2HC1C(-0.67), NR1H2(-0.66), ...&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=13</id>
		<title>IRF2BP2</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=13"/>
				<updated>2018-01-26T07:34:39Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
Alternative splicing results in multiple transcript variants encoding distinct isoforms.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
IRF2BP2 interacts with the C-terminal transcriptional repression domain of IRF2. &lt;br /&gt;
&lt;br /&gt;
Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. &lt;br /&gt;
&lt;br /&gt;
Represses the NFAT1-dependent transactivation of NFAT-responsive promoters. &lt;br /&gt;
&lt;br /&gt;
Acts as a coactivator of VEGFA expression in cardiac and skeletal muscle&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Northern blot analysis revealed high levels of IRF2BP2 mRNA in adult human heart and skeletal muscles, &lt;br /&gt;
'''but immunoblot analysis showed low levels of IRF2BP2 protein in skeletal muscle, indicating post-transcriptional regulation of IRF2BP2 expression''' &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
IRF2BP2 protein levels are markedly increased by ischemia in skeletal and cardiac muscle compared to normoxic controls. &lt;br /&gt;
IRF2BP2 is a novel ischemia-induced coactivator of VEGFA expression that may contribute to revascularization of ischemic cardiac and skeletal muscles&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
... todo&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with IRF2BP2 include Mesenchymal Chondrosarcoma and Common Variable Immunodeficiency.&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=20702774&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise.&lt;br /&gt;
&lt;br /&gt;
[[File:IRF2BP2.png|IRF2BP2 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|Gene&lt;br /&gt;
|SIAH2&lt;br /&gt;
|MNT&lt;br /&gt;
|WBP1L&lt;br /&gt;
|BHLHE40&lt;br /&gt;
|SLC25A25&lt;br /&gt;
|ELMSAN1&lt;br /&gt;
|PIP5K1C&lt;br /&gt;
|ARID5B&lt;br /&gt;
|CTGF&lt;br /&gt;
|KLF11&lt;br /&gt;
|CX3CL1&lt;br /&gt;
|LRRC8A&lt;br /&gt;
|- &lt;br /&gt;
|r&lt;br /&gt;
|0.7785532&lt;br /&gt;
|0.7768744&lt;br /&gt;
|0.7723620&lt;br /&gt;
|0.7699279&lt;br /&gt;
|0.7516998&lt;br /&gt;
|0.7476651&lt;br /&gt;
|0.7470779&lt;br /&gt;
|0.7165333&lt;br /&gt;
|0.7135609&lt;br /&gt;
|0.7129015&lt;br /&gt;
|0.7070233&lt;br /&gt;
|0.7015876&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=GCH1&amp;diff=12</id>
		<title>GCH1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=GCH1&amp;diff=12"/>
				<updated>2018-01-26T07:34:17Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This gene encodes a member of the GTP cyclohydrolase family. &lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. &lt;br /&gt;
&lt;br /&gt;
BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. &lt;br /&gt;
&lt;br /&gt;
GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate&lt;br /&gt;
&lt;br /&gt;
May modify pain sensitivity and persistence &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Kinetics====&lt;br /&gt;
KM=116 µM for GTP &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Pathways====&lt;br /&gt;
7,8-dihydroneopterin triphosphate biosynthesis&lt;br /&gt;
eNOS activation&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Hyperphenylalaninemia, Bh4-Deficient, B and Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=24373571&lt;br /&gt;
#2 pmid=2500984&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:GCH1.png|GCH1 expression]]&lt;br /&gt;
&lt;br /&gt;
[[Category:muscle_DEGs]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:GCH1.png&amp;diff=11</id>
		<title>File:GCH1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:GCH1.png&amp;diff=11"/>
				<updated>2018-01-26T02:55:25Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=GCH1&amp;diff=10</id>
		<title>GCH1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=GCH1&amp;diff=10"/>
				<updated>2018-01-26T02:52:51Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This gene encodes a member of the GTP cyclohydrolase family. &lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. &lt;br /&gt;
&lt;br /&gt;
BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. &lt;br /&gt;
&lt;br /&gt;
GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate&lt;br /&gt;
&lt;br /&gt;
May modify pain sensitivity and persistence &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Kinetics====&lt;br /&gt;
KM=116 µM for GTP &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Pathways====&lt;br /&gt;
7,8-dihydroneopterin triphosphate biosynthesis&lt;br /&gt;
eNOS activation&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Hyperphenylalaninemia, Bh4-Deficient, B and Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=24373571&lt;br /&gt;
#2 pmid=2500984&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:GCH1.png|GCH1 expression]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=GCH1&amp;diff=9</id>
		<title>GCH1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=GCH1&amp;diff=9"/>
				<updated>2018-01-26T02:48:51Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;This gene encodes a member of the GTP cyclohydrolase family.   ====Action==== The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthes...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This gene encodes a member of the GTP cyclohydrolase family. &lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. &lt;br /&gt;
&lt;br /&gt;
BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. &lt;br /&gt;
&lt;br /&gt;
GTP + H2O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate&lt;br /&gt;
&lt;br /&gt;
May modify pain sensitivity and persistence &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
====Pathways====&lt;br /&gt;
eNOS activation&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Hyperphenylalaninemia, Bh4-Deficient, B and Dystonia, Dopa-Responsive, With Or Without Hyperphenylalaninemia. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=24373571&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - after 1 hour after exercises.&lt;br /&gt;
&lt;br /&gt;
[[File:GCH1.png|GCH1 expression]]&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:GSH1.png&amp;diff=8</id>
		<title>File:GSH1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:GSH1.png&amp;diff=8"/>
				<updated>2018-01-26T02:45:13Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=7</id>
		<title>IRF2BP2</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=7"/>
				<updated>2018-01-26T02:25:34Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
Alternative splicing results in multiple transcript variants encoding distinct isoforms.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
IRF2BP2 interacts with the C-terminal transcriptional repression domain of IRF2. &lt;br /&gt;
&lt;br /&gt;
Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. &lt;br /&gt;
&lt;br /&gt;
Represses the NFAT1-dependent transactivation of NFAT-responsive promoters. &lt;br /&gt;
&lt;br /&gt;
Acts as a coactivator of VEGFA expression in cardiac and skeletal muscle&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Northern blot analysis revealed high levels of IRF2BP2 mRNA in adult human heart and skeletal muscles, &lt;br /&gt;
'''but immunoblot analysis showed low levels of IRF2BP2 protein in skeletal muscle, indicating post-transcriptional regulation of IRF2BP2 expression''' &amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
IRF2BP2 protein levels are markedly increased by ischemia in skeletal and cardiac muscle compared to normoxic controls. &lt;br /&gt;
IRF2BP2 is a novel ischemia-induced coactivator of VEGFA expression that may contribute to revascularization of ischemic cardiac and skeletal muscles&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
... todo&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with IRF2BP2 include Mesenchymal Chondrosarcoma and Common Variable Immunodeficiency.&lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=20702774&lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise.&lt;br /&gt;
&lt;br /&gt;
[[File:IRF2BP2.png|IRF2BP2 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|Gene&lt;br /&gt;
|SIAH2&lt;br /&gt;
|MNT&lt;br /&gt;
|WBP1L&lt;br /&gt;
|BHLHE40&lt;br /&gt;
|SLC25A25&lt;br /&gt;
|ELMSAN1&lt;br /&gt;
|PIP5K1C&lt;br /&gt;
|ARID5B&lt;br /&gt;
|CTGF&lt;br /&gt;
|KLF11&lt;br /&gt;
|CX3CL1&lt;br /&gt;
|LRRC8A&lt;br /&gt;
|- &lt;br /&gt;
|r&lt;br /&gt;
|0.7785532&lt;br /&gt;
|0.7768744&lt;br /&gt;
|0.7723620&lt;br /&gt;
|0.7699279&lt;br /&gt;
|0.7516998&lt;br /&gt;
|0.7476651&lt;br /&gt;
|0.7470779&lt;br /&gt;
|0.7165333&lt;br /&gt;
|0.7135609&lt;br /&gt;
|0.7129015&lt;br /&gt;
|0.7070233&lt;br /&gt;
|0.7015876&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=6</id>
		<title>MEOX1</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=MEOX1&amp;diff=6"/>
				<updated>2018-01-24T17:01:22Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development.   Required for maintenance of the sclerotome po...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Mesodermal transcription factor that plays a key role in somitogenesis and is specifically required for sclerotome development. &lt;br /&gt;
&lt;br /&gt;
Required for maintenance of the sclerotome polarity and formation of the cranio-cervical joints (PubMed:23290072, PubMed:24073994). &lt;br /&gt;
&lt;br /&gt;
&amp;lt;cite&amp;gt;1&amp;lt;/cite&amp;gt; - The formation of skeletal muscle: from somite to limb&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
http://www.uniprot.org/uniprot/P50221#function&lt;br /&gt;
&lt;br /&gt;
Binds specifically to the promoter of target genes and regulates their expression. &lt;br /&gt;
&lt;br /&gt;
Activates expression of NKX3-2 in the sclerotome. &lt;br /&gt;
&lt;br /&gt;
Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation. &lt;br /&gt;
&lt;br /&gt;
While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner. &lt;br /&gt;
&lt;br /&gt;
Required for hematopoietic stem cell (HSCs) induction via its role in somitogenesis: &lt;br /&gt;
specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the somite named endotome.&lt;br /&gt;
&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;2&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 promotes vascular smooth muscle cells (SMCs) phenotypic modulation and injury-induced vascular remodeling by regulating the FAK-ERK1/2-autophagy signaling cascade&amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Meox1 initiates G2 cell-cycle arrest within muscle stem cells&amp;lt;cite&amp;gt;4&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Pax3 is both necessary and sufficient to induce skeletal myogenesis, Meox1 is required for Pax3 expression and subsequent myogenic differentiation ([21–23] in &amp;lt;cite&amp;gt;5&amp;lt;/cite&amp;gt;).&lt;br /&gt;
&lt;br /&gt;
Transduction of hAFS (human amniotic fluid stem) cells with MYOD lentiviruses induces skeletal myogenic differentiation in vitro and morphological and functional regeneration of injured muscle in vivo.&lt;br /&gt;
Analysis of pre-myogenic factors showed that expression of PAX3, MEOX1 and EYA2 was significantly increased by MYOD &amp;lt;cite&amp;gt;6&amp;lt;/cite&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
ERK1/2 for vascular smooth muscle cells (SMCs) &amp;lt;cite&amp;gt;3&amp;lt;/cite&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with MEOX1 include Klippel-Feil Syndrome 2 and Isolated Klippel-Feil Syndrome. &lt;br /&gt;
&lt;br /&gt;
====References====&lt;br /&gt;
&amp;lt;biblio&amp;gt;&lt;br /&gt;
#1 pmid=12587921&lt;br /&gt;
#2 pmid=24331373&lt;br /&gt;
#3 pmid=29113690&lt;br /&gt;
#4 pmid=28686860&lt;br /&gt;
#5 pmid=28469839&lt;br /&gt;
#6 pmid=24331373 &lt;br /&gt;
&amp;lt;/biblio&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise and has increased level after long training.&lt;br /&gt;
&lt;br /&gt;
[[File:MEOX1.png|MEOX1 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
VASP (0.89), CDC42EP1 (0.88), IQCJ-SCHIP1 (0.87), TES(0.87), ABRACL(0.87), KCNK6(0.87), TINAGL1(0.87), GLIS2(0.86), PCGF2(0.86), IL27RA(0.86), VWA1(0.86), PLEKHG2(0.85), PDGFB(0.85), &lt;br /&gt;
ENG(0.85), ERF(0.85), SHROOM1(0.84), FAM57A(0.84), ELFN1(0.84), PPP1R13L(0.84), ITGA5(0.84), RAB32(0.84), MYADM(0.84), RNF152(0.83), CNN2(0.83), CDR2L(0.83), TMC6(0.83),&lt;br /&gt;
ZBTB46(0.83), NOVA2(0.87), TGFB1I1(0.83), ELF4(0.83), PGM2(0.83), GBP1(0.83), PRKD2(0.83), NOL4L(0.82), SH2D3C(0.82), ZYX(0.82), TPM4(0.82), EPHA2(0.82), NECTIN2(0.82),&lt;br /&gt;
SERPINH1(0.82), ACTN4(0.82), MMRN2(0.81), TAL1(0.82), SPATA2L(0.81), TRIM47(0.81), TGFB1(0.81), MYH9(0.81), LCP2(0.81), YWHAH(0.81), BCL6B(0.81), DLL1(0.80),&lt;br /&gt;
TAGLN2(0.80), TBC1D9(0.80), SOX18(0.80), ID2(0.80), TAGLN2P1(0.80), MARCKSL1(0.80), MYL6P5(0.80), DLC1(0.79), ACTG1(0.79), HEYL(0.79), KCTD15(0.79), ...&lt;br /&gt;
&lt;br /&gt;
HOXA10(-0.76), CLCN1(-0.71), KIF1C(-0.70), ZNF865(-0.68), RYR1(-0.67), ZC2HC1C(-0.67), NR1H2(-0.66), ...&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:MEOX1.png&amp;diff=5</id>
		<title>File:MEOX1.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:MEOX1.png&amp;diff=5"/>
				<updated>2018-01-24T15:55:13Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=4</id>
		<title>IRF2BP2</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=4"/>
				<updated>2018-01-23T10:56:40Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
Alternative splicing results in multiple transcript variants encoding distinct isoforms.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
IRF2BP2 interacts with the C-terminal transcriptional repression domain of IRF2. &lt;br /&gt;
&lt;br /&gt;
Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. &lt;br /&gt;
&lt;br /&gt;
Represses the NFAT1-dependent transactivation of NFAT-responsive promoters. &lt;br /&gt;
&lt;br /&gt;
Acts as a coactivator of VEGFA expression in cardiac and skeletal muscle.&lt;br /&gt;
&lt;br /&gt;
====Pathways====&lt;br /&gt;
... todo&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with IRF2BP2 include Mesenchymal Chondrosarcoma and Common Variable Immunodeficiency.&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise.&lt;br /&gt;
&lt;br /&gt;
[[File:IRF2BP2.png|IRF2BP2 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|Gene&lt;br /&gt;
|SIAH2&lt;br /&gt;
|MNT&lt;br /&gt;
|WBP1L&lt;br /&gt;
|BHLHE40&lt;br /&gt;
|SLC25A25&lt;br /&gt;
|ELMSAN1&lt;br /&gt;
|PIP5K1C&lt;br /&gt;
|ARID5B&lt;br /&gt;
|CTGF&lt;br /&gt;
|KLF11&lt;br /&gt;
|CX3CL1&lt;br /&gt;
|LRRC8A&lt;br /&gt;
|- &lt;br /&gt;
|r&lt;br /&gt;
|0.7785532&lt;br /&gt;
|0.7768744&lt;br /&gt;
|0.7723620&lt;br /&gt;
|0.7699279&lt;br /&gt;
|0.7516998&lt;br /&gt;
|0.7476651&lt;br /&gt;
|0.7470779&lt;br /&gt;
|0.7165333&lt;br /&gt;
|0.7135609&lt;br /&gt;
|0.7129015&lt;br /&gt;
|0.7070233&lt;br /&gt;
|0.7015876&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=3</id>
		<title>IRF2BP2</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=IRF2BP2&amp;diff=3"/>
				<updated>2018-01-23T10:53:36Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: Created page with &amp;quot;IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2) is a Protein Coding gene.   Alternative splicing results in multiple transcript variants encoding distinct isoforms....&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;IRF2BP2 (Interferon Regulatory Factor 2 Binding Protein 2) is a Protein Coding gene. &lt;br /&gt;
&lt;br /&gt;
Alternative splicing results in multiple transcript variants encoding distinct isoforms.&lt;br /&gt;
&lt;br /&gt;
====Action====&lt;br /&gt;
IRF2BP2 interacts with the C-terminal transcriptional repression domain of IRF2. &lt;br /&gt;
&lt;br /&gt;
Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities. &lt;br /&gt;
&lt;br /&gt;
Represses the NFAT1-dependent transactivation of NFAT-responsive promoters. &lt;br /&gt;
&lt;br /&gt;
Acts as a coactivator of VEGFA expression in cardiac and skeletal muscle.&lt;br /&gt;
&lt;br /&gt;
====Diseases====&lt;br /&gt;
Diseases associated with IRF2BP2 include Mesenchymal Chondrosarcoma and Common Variable Immunodeficiency.&lt;br /&gt;
&lt;br /&gt;
====Expression====&lt;br /&gt;
Upregulated - mainly after 1 hour after exercise.&lt;br /&gt;
&lt;br /&gt;
[[File:IRF2BP2.png|IRF2BP2 expression]]&lt;br /&gt;
&lt;br /&gt;
====Coregulation====&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|Gene&lt;br /&gt;
|SIAH2&lt;br /&gt;
|MNT&lt;br /&gt;
|WBP1L&lt;br /&gt;
|BHLHE40&lt;br /&gt;
|SLC25A25&lt;br /&gt;
|ELMSAN1&lt;br /&gt;
|PIP5K1C&lt;br /&gt;
|ARID5B&lt;br /&gt;
|CTGF&lt;br /&gt;
|KLF11&lt;br /&gt;
|CX3CL1&lt;br /&gt;
|LRRC8A&lt;br /&gt;
|- &lt;br /&gt;
|r&lt;br /&gt;
|0.7785532&lt;br /&gt;
|0.7768744&lt;br /&gt;
|0.7723620&lt;br /&gt;
|0.7699279&lt;br /&gt;
|0.7516998&lt;br /&gt;
|0.7476651&lt;br /&gt;
|0.7470779&lt;br /&gt;
|0.7165333&lt;br /&gt;
|0.7135609&lt;br /&gt;
|0.7129015&lt;br /&gt;
|0.7070233&lt;br /&gt;
|0.7015876&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	<entry>
		<id>http://muscle.biouml.org/index.php?title=File:IRF2BP2.png&amp;diff=2</id>
		<title>File:IRF2BP2.png</title>
		<link rel="alternate" type="text/html" href="http://muscle.biouml.org/index.php?title=File:IRF2BP2.png&amp;diff=2"/>
				<updated>2018-01-23T10:20:29Z</updated>
		
		<summary type="html">&lt;p&gt;Fedor: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Fedor</name></author>	</entry>

	</feed>